SERPINE1 and type 2 diabetes mellitus: Decreased clot susceptibility to fibrinolysis, together with high levels of plasminogen activator inhibitor-1 (PAI-1), which is typical of T2DM [10] and associated with abdominal obesity [5], may contribute to an increased atherothrombotic risk in this disease.